Illumina | ILMN - Ebitda




Illumina reported $229M in EBITDA for its fiscal quarter ending in December of 2024.

Ebitda Change Date
Agilent USD 504M 35M Oct/2024
Bio Techne USD 81.15M 8.92M Sep/2024
Bio-Rad Laboratories USD 126.11M 19.25M Dec/2024
Boston Scientific USD 1.25B 105M Dec/2024
Bruker USD 161.7M 29.3M Dec/2024
Charles River Laboratories USD 192.3M 43.95M Dec/2024
Danaher USD 2.02B 365M Dec/2024
Dentsply International USD -371000000 508M Sep/2024
Edwards Lifesciences USD 333.3M 95.1M Dec/2024
Exact Sciences USD 34.03M 837K Sep/2024
Hologic USD 301M 19.4M Dec/2024
Illumina USD 229M 100M Dec/2024
Intuitive Surgical USD 749.5M 56M Dec/2024
IQVIA Holdings USD 856M 12M Sep/2024
Laboratory Of America USD 483.6M 22.5M Dec/2024
Mettler Toledo International USD 365.41M 54.15M Dec/2024
Myriad Genetics USD -2200000 19.1M Sep/2024
Quest Diagnostics USD 513M 34M Dec/2024
Quidel USD 142.8M 9M Dec/2024
Repligen USD 4.9M 22.12M Sep/2024
Revvity USD 215.64M 4.12M Dec/2024
Roche Holding CHF 12.68B 2.36B Jun/2024
Standard Biotools USD -20387000 17.74M Sep/2024
Thermo Fisher Scientific USD 2.99B 149M Dec/2024
Waters USD 343.66M 81.1M Dec/2024